Guangzhou Wondfo Biotech Co (SZSE:300482) ROCE % : 17.99% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Guangzhou Wondfo Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Guangzhou Wondfo Biotech Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 17.99%.

Guangzhou Wondfo Biotech Co ROCE % Historical Data

The historical data trend for Guangzhou Wondfo Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Wondfo Biotech Co ROCE % Chart

Guangzhou Wondfo Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

21.72

24.62

18.66

30.26

10.92

Guangzhou Wondfo Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															18.15	12.00	5.90	6.70	17.99

Guangzhou Wondfo Biotech Co ROCE % Calculation

Guangzhou Wondfo Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	570.697	/	( ( (6301.311 - 1141.055)	+	(5771.717 - 484.227) )	/ 2 )
	=	570.697	/	( (5160.256	+	5287.49)	/ 2 )
	=	570.697	/	5223.873
	=	10.92 %

Guangzhou Wondfo Biotech Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	1034.992	/	( ( (5771.717 - 484.227)	+	(6673.95 - 455.509) )	/ 2 )
	=	1034.992	/	( ( 5287.49	+	6218.441 )	/ 2 )
	=	1034.992	/	5752.9655
	=	17.99 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Guangzhou Wondfo Biotech Co (SZSE:300482) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Guangzhou Wondfo Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Guangzhou Wondfo Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangzhou Wondfo Biotech Co (SZSE:300482) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Lizhishan Road, Science City, Luogang District, Guangdong, Guangzhou, CHN, 510641

Website

http://www.wondfo.com.cn

Guangzhou Wondfo Biotech Co Ltd manufactures medical diagnostic tests. Its products include immunodiagnostic rapid test kits, including fertility, which include pregnancy HCG, ovulation LH, and others. The company's products are used in a clinical test, field test, and personal health management, among others.

Executives

He Xiao Wei	Director
Kang Ke Ren	Executives
Yu Fang Xia	Executives
Li Wen Mei	Directors, executives
Wang Ji Hua	Director
Peng Zhong Xiong	Executives
Zhao Ya Ping	Executives
Luo Hong	Supervisors
Zhou Yong	Supervisors

Guangzhou Wondfo Biotech Co (SZSE:300482) Headlines

No Headlines